Automated Cell Counters Market Size Worth $10.36Bn, Globally, by 2028 Growing at 5.9% CAGR – Exclusive Report by The Insight Partners
27 juil. 2022 06h03 HE
|
The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Automated Cell Counters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type,...
Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test
06 juil. 2022 08h00 HE
|
Hemex Health
PORTLAND, Ore. and PUNE, India, July 06, 2022 (GLOBE NEWSWIRE) -- Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device...
Positive New Data from Phase 1/2 Trial of AT-01 (Iodine I-124 Evuzamitide) Presented at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
14 juin 2022 11h45 HE
|
Attralus, Inc
AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific changes in amyloid load over time AT-01 detected...
Attralus to Present New AT-01 Data at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
03 juin 2022 08h00 HE
|
Attralus, Inc
Final Phase 1/2 Study Results for AT-01 (Evuzamitide), Attralus's Novel Pan-Amyloid Imaging Agent for the Detection of Systemic Amyloidosis Repeat PET/CT Imaging of a Patient with Systemic Amyloidosis...
Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology
02 juin 2022 16h10 HE
|
Adaptive Biotechnologies
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Data from Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
08 mai 2022 06h00 HE
|
Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...
Endominance Launches Exciting New Microbiome, Anxiety, and Cognitive Orientation Study
14 avr. 2022 17h00 HE
|
Endominance, Inc.
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Endominance, Inc., a leading cognitive assessment and data collection firm headquartered in Virginia, today announced the launch of a...
Global $27+ Million Endoscopy Equipment and Software Market is Expected to Grow at a CAGR of over 6.20% During 2022-2028 | Vantage Market Research
05 avr. 2022 05h46 HE
|
Vantage Market Research
WASHINGTON, April 05, 2022 (GLOBE NEWSWIRE) -- The "Endoscopy Equipment and Software Market Size, Share & Trends Analysis Report by Product (Endoscope, Visualization Systems, Software,...
Positive New Data from Phase 1/2 Trial of AT-01 Presented at 2022 American College of Cardiology Annual Scientific Session
04 avr. 2022 08h00 HE
|
Attralus, Inc
AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac disease was 100% in ATTR and 93% in ALCardiac...
Medical Database, Inc. Integrates Its Laboratory Decision System, LDS®, With Epic
23 mars 2022 10h01 HE
|
Medical Database, Inc
IRVINE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Medical Database, Inc., an innovative provider of clinical laboratory and medical content, today announced the successful integration of its...